3-(2-(2-(3'-fluoro-2'-(methoxycarbonyl)biphenyl-4-yl)ethyl)-5-neopentyl-1H-imidazol-1-yl)propanoic acid

ID: ALA4461212

Chembl Id: CHEMBL4461212

PubChem CID: 155528415

Max Phase: Preclinical

Molecular Formula: C27H31FN2O4

Molecular Weight: 466.55

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)c1c(F)cccc1-c1ccc(CCc2ncc(CC(C)(C)C)n2CCC(=O)O)cc1

Standard InChI:  InChI=1S/C27H31FN2O4/c1-27(2,3)16-20-17-29-23(30(20)15-14-24(31)32)13-10-18-8-11-19(12-9-18)21-6-5-7-22(28)25(21)26(33)34-4/h5-9,11-12,17H,10,13-16H2,1-4H3,(H,31,32)

Standard InChI Key:  HAILRGHMXHIZSJ-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4461212

    ---

Associated Targets(Human)

BRS3 Tchem Bombesin receptor subtype-3 (700 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Brs3 Bombesin receptor subtype-3 (412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 466.55Molecular Weight (Monoisotopic): 466.2268AlogP: 5.32#Rotatable Bonds: 9
Polar Surface Area: 81.42Molecular Species: ACIDHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 4.53CX Basic pKa: 7.53CX LogP: 4.44CX LogD: 4.21
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.43Np Likeness Score: -0.77

References

1. Kiyotsuka Y, Shimada K, Kobayashi S, Suzuki M, Akiu M, Asano M, Sogawa Y, Hara T, Konishi M, Abe-Ohya R, Izumi M, Nagai Y, Yoshida K, Abe Y, Takamori H, Takahashi H..  (2016)  Synthesis and biological evaluation of novel imidazol-1-ylacetic acid derivatives as non-brain penetrant bombesin receptor subtype-3 (BRS-3) agonists.,  26  (17): [PMID:27491709] [10.1016/j.bmcl.2016.07.056]

Source